A series of hydroxy- and polyhydroxy-anthraquinones were screened for
inhibitory activity against the malarial parasite, Plasmodium falcipar
um. Rufigallol demonstrated the most potent effects with a 50% inhibit
ory concentration (IC50) value of similar to 10.5 ng/ml (similar to 35
nM). Deleterious effects were exerted by rufigallol toward bone marro
w progenitor cells at concentrations greater than or equal to 10 mu M
(3 mu g/ml) where similar to 30% suppression of colony growth was note
d. Taking into consideration its potency and relative lack of toxicity
, we believe that rufigallol should be advanced for in vivo studies. A
t the very least, rufigallol represents a simple, inexpensive lead dru
g for the development of more potent analogs.